We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Ms
Corinne
Collett
-
C.Collett@uea.ac.uk
Prof
Eleanor
Scott
+44 (0)113 343 7762
E.M.Scott@leeds.ac.uk
Prof
Helen R
Murphy
+44 (0)1603 591657
Helen.Murphy@uea.ac.uk
Dr
Study
Team
-
protect.trial@uea.ac.uk
Early-onset type 2 diabetes in pregnancy
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Previous studies have shown that Continuous Glucose Monitoring (CGM) improves maternal glucose, reduces neonatal admissions and is clinically and cost-effective in type 1 diabetes (T1D) pregnancy, and as a result CGM is now standard care in T1D pregnancy. However, there are no well-designed adequately powered trials to compare CGM and standard care monitoring of blood glucose in type 2 diabetes (T2D) pregnancy.
The purpose of this study is to examine whether using CGM improves glucose levels in pregnant women with T2D and whether it leads to better outcomes for the baby. We will also look at its impact on maternal wellbeing, diabetes treatment satisfaction, and cost effectiveness.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Non-type 2 diabetes2. Chronic kidney disease (CKD) grade 4 or 5 (GFR < 30ml/min)3. Severe visual impairment
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Prof
Eleanor
Scott
+44 (0)113 343 7762
E.M.Scott@leeds.ac.uk
Dr
Study
Team
-
protect.trial@uea.ac.uk
Prof
Helen R
Murphy
+44 (0)1603 591657
Helen.Murphy@uea.ac.uk
Ms
Corinne
Collett
-
C.Collett@uea.ac.uk
The study is sponsored by University of East Anglia and funded by NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 58352
You can print or share the study information with your GP/healthcare provider or contact the research team directly.